Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01860703).
- Evaluations of Alcohol Warning Labels: Complete Statistical AnalysisIndependent statistical analysis of Evaluations of Alcohol Warning Labels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06129487).
- EVARIndependent statistical analysis of Combination of E-cigarettes and Varenicline for Tobacco Harm Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04210180).
- EVarQuitIndependent statistical analysis of EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03262662).
- EVAS2Independent statistical analysis of EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity: Complete Statistical AnalysisIndependent statistical analysis of Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex: Complete Statistical AnalysisIndependent statistical analysis of Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Everolimus for Cancer With TSC1 or TSC2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Everolimus for Cancer With TSC1 or TSC2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02201212).
- Everolimus for Children With Recurrent or Progressive Ependymoma: Complete Statistical AnalysisIndependent statistical analysis of Everolimus for Children With Recurrent or Progressive Ependymoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02155920).
- Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.: Complete Statistical AnalysisIndependent statistical analysis of Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EVERZOTAIndependent statistical analysis of Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EVIDENCEIndependent statistical analysis of Evaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and Treatment: primary endpoint results, effect estimate with confidence interval,…
- EvidenceIndependent statistical analysis of Spinal Cord Stimulation With Precision® System Versus Reoperation for Failed Back Surgery Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Evidence-based Intervention for Improved Head Impact Safety in Youth Football – Aim 1 and Aim 3: Complete Statistical AnalysisIndependent statistical analysis of Evidence-based Intervention for Improved Head Impact Safety in Youth Football - Aim 1 and Aim 3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- EVIPIndependent statistical analysis of Etanercept and Vascular Function in Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01989689).
- EVITAIndependent statistical analysis of 24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance…
- EVITAIndependent statistical analysis of Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EvKIndependent statistical analysis of Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- EVOGUARDIndependent statistical analysis of Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EVOKEIndependent statistical analysis of Safety and Efficacy Study of the Evoke™ SCS System With Feedback vs. Conventional Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- EVOLVEIndependent statistical analysis of Epanova® for Lowering Very High Triglycerides: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01242527).
- EVOLVE48Independent statistical analysis of A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- EVOLVEIIIndependent statistical analysis of Epanova® for Lowering Very High Triglycerides II (EVOLVE II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02009865).
- EVTGCIndependent statistical analysis of Evaluation of Videoconferencing Versus Telephone Genetic Counseling: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02108977).
- EW-DIndependent statistical analysis of A Community Wellness Program for Adults Living With Long-term Physical Disability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia: Complete Statistical AnalysisIndependent statistical analysis of EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies: primary endpoint results, effect estimate with…
- Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EXAMINERIndependent statistical analysis of A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing: Complete Statistical AnalysisIndependent statistical analysis of Examining How a Text Message-based Educational Intervention Influences COVID-19 Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07074171).
- Examining the Impact of Family Connectors: Complete Statistical AnalysisIndependent statistical analysis of Examining the Impact of Family Connectors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05195489).
- ExCelA complete statistical analysis of the ExCel phase 3 trial of exemestane for breast cancer prevention in postmenopausal women at increased risk, including trial design, breast cancer-free survival, hazard ratios, confidence intervals,…
- ExCeLIndependent statistical analysis of EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EXCELIndependent statistical analysis of Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Exemestane in Treating Postmenopausal Women With Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00810797).
- Exenatide in Extreme Pediatric Obesity: Complete Statistical AnalysisIndependent statistical analysis of Exenatide in Extreme Pediatric Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01237197).
- Exercise and QUality Diet After Leukemia: The EQUAL Study: Complete Statistical AnalysisIndependent statistical analysis of Exercise and QUality Diet After Leukemia: The EQUAL Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02244411).
- Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03355469).
- Exercise for Swallowing Problems After Stroke: Complete Statistical AnalysisIndependent statistical analysis of Exercise for Swallowing Problems After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00722111).
- Exercise From Afar: Progressing At Risk Individuals to Independent Exercise: Complete Statistical AnalysisIndependent statistical analysis of Exercise From Afar: Progressing At Risk Individuals to Independent Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06667817).
- Exercise Pulmonary Transit Time: Complete Statistical AnalysisIndependent statistical analysis of Exercise Pulmonary Transit Time: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04336995).
- Exercise Training and Cognitive Function in Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Exercise Training and Cognitive Function in Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03197038).
- Exercise Training in Heart Failure: Changes in Cardiac Structure and Function: Complete Statistical AnalysisIndependent statistical analysis of Exercise Training in Heart Failure: Changes in Cardiac Structure and Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Exercise Training to Improve Cognitive Function: Complete Statistical AnalysisIndependent statistical analysis of Exercise Training to Improve Cognitive Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03824639).
- Exercise-induced Hypoalgesia After Comparative Forms of Exercise: Complete Statistical AnalysisIndependent statistical analysis of Exercise-induced Hypoalgesia After Comparative Forms of Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01883895).
- Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload: Complete Statistical AnalysisIndependent statistical analysis of Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.: Complete Statistical AnalysisIndependent statistical analysis of Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.: primary endpoint results,…
- Exparel for Total Shoulder Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Exparel for Total Shoulder Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04364867).
- Exparel vs. Standard Bupivicaine for Abdominoplasty: Complete Statistical AnalysisIndependent statistical analysis of Exparel vs. Standard Bupivicaine for Abdominoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01853176).